FDA Inspection 1170239 — Intermountain Medical Center
The FDA completed an inspection of Intermountain Medical Center on May 12, 2022 in Murray, UT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 12, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Murray, UT (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 166 | 21 CFR 606.170(a) | Adverse reaction - Disposition of Reports |